LD-2 disclosure · 4th Quarter - Report
RANBAXY INC.
Client
- Name
- RANBAXY INC.
- Description
- Pharmaceuticals
- Location
- New Jersey · United States of America
Registrant
- Description
- Law Firm
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
S.27, Preserve Acess to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Prescription Drug User Fee Reauthorization issues.
Lobbyistsmr MATTHEW TODD TUTEN · ANURAG VARMA · JOHN JONAS · ERIC RASMUSSEN · mrs KENDALL BYRUM HUSSEY
Covered position (mr MATTHEW TODD TUTEN): RepMichaelBilirakis91-92;93-95;98-01
Covered position (ERIC RASMUSSEN): SenCrapoLA04-07andDepPresSec03-02LegIntenHatch2000
Covered position (mrs KENDALL BYRUM HUSSEY): SenHealthLaborPensionCom2005-08
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
S. 27, Preserve Access to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care Act; Prescription Drug User Fee Reauthorization issues; H.R. 8, the American Taxpayer Relief Act.
Lobbyistsmr MATTHEW TODD TUTEN · ANURAG VARMA · JOHN JONAS · ERIC RASMUSSEN · mrs KENDALL BYRUM HUSSEY
Covered position (mr MATTHEW TODD TUTEN): RepMichaelBilirakis91-92;93-95;98-01
Covered position (ERIC RASMUSSEN): SenCrapoLA04-07andDepPresSec03-02LegIntenHatch2000
SenHealthLaborPensionCom2005-08